MAGHNIE, MOHAMAD
 Distribuzione geografica
Continente #
EU - Europa 28.186
AS - Asia 3.066
NA - Nord America 1.193
SA - Sud America 231
AF - Africa 62
OC - Oceania 4
Totale 32.742
Nazione #
IT - Italia 27.707
SG - Singapore 1.384
US - Stati Uniti d'America 1.132
CN - Cina 835
VN - Vietnam 497
FR - Francia 232
BR - Brasile 130
HK - Hong Kong 116
FI - Finlandia 61
DE - Germania 44
AR - Argentina 40
JP - Giappone 38
MX - Messico 30
NL - Olanda 28
ID - Indonesia 25
CH - Svizzera 24
GB - Regno Unito 23
BD - Bangladesh 22
IN - India 22
EC - Ecuador 18
IQ - Iraq 16
PK - Pakistan 16
CA - Canada 15
RU - Federazione Russa 14
CO - Colombia 13
VE - Venezuela 12
PH - Filippine 11
EG - Egitto 10
TR - Turchia 10
MA - Marocco 9
TH - Thailandia 9
ZA - Sudafrica 8
MY - Malesia 7
UA - Ucraina 7
CL - Cile 6
ES - Italia 6
IE - Irlanda 6
JO - Giordania 6
OM - Oman 6
RO - Romania 6
TN - Tunisia 6
DZ - Algeria 5
IL - Israele 5
SN - Senegal 5
UZ - Uzbekistan 5
AU - Australia 4
IR - Iran 4
KE - Kenya 4
KR - Corea 4
PL - Polonia 4
PY - Paraguay 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
CR - Costa Rica 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CG - Congo 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
LV - Lettonia 1
MG - Madagascar 1
MN - Mongolia 1
MU - Mauritius 1
PR - Porto Rico 1
SE - Svezia 1
SL - Sierra Leone 1
TG - Togo 1
Totale 32.740
Città #
Genova 15.559
Genoa 7.703
Rapallo 2.260
Vado Ligure 1.962
Singapore 671
San Jose 408
Ashburn 221
Lauterbourg 217
Ho Chi Minh City 154
Beijing 125
Hong Kong 112
Hanoi 108
Council Bluffs 81
Helsinki 59
Bordighera 58
New York 55
Santa Clara 35
Tokyo 32
Frankfurt am Main 31
Milan 31
Boardman 25
Zurich 24
Da Nang 23
Tianjin 22
Haiphong 18
Los Angeles 18
Mexico City 17
Chicago 16
Orem 14
Amsterdam 13
São Paulo 12
Turin 12
Can Tho 11
Rome 11
Montreal 10
Baghdad 8
Des Moines 8
Buffalo 7
Cardiff 7
Guayaquil 7
Hải Dương 7
Quito 7
Shanghai 7
Biên Hòa 6
Caracas 6
Dallas 6
Guangzhou 6
Istanbul 6
Atlanta 5
Bangkok 5
Belo Horizonte 5
Cairo 5
City of London 5
Dakar 5
Dublin 5
Kuala Lumpur 5
Naples 5
Ninh Bình 5
Thái Nguyên 5
Amman 4
Bologna 4
Bến Tre 4
Casablanca 4
Cassano Magnago 4
Dhaka 4
Houston 4
La Spezia 4
Lahore 4
Long Xuyen 4
Medellín 4
Nairobi 4
Nuremberg 4
Palermo 4
Phủ Lý 4
Porto Alegre 4
Rio de Janeiro 4
Thái Bình 4
Toronto 4
Valenza 4
Warsaw 4
Brasília 3
Brescia 3
Bắc Ninh 3
Chennai 3
Karachi 3
Lima 3
Lomazzo 3
London 3
Madrid 3
Quảng Nam Province 3
Quảng Ngãi 3
Seeb 3
Shenyang 3
Shenzhen 3
Tampa 3
Tashkent 3
Tel Aviv 3
Tân Tiến 3
Zhengzhou 3
Điện Bàn 3
Totale 30.415
Nome #
Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging. 591
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. 296
A longitudinal printo study on growth and puberty in juvenile systemic lupus erythematosus. 233
Age- and sex-matched reference curves for serum collagen type I C-telopeptides and bone alkaline phosphatase in children and adolescents: An alternative multivariate statistical analysis approach 225
Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies 222
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 212
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 197
Classical and non-classical causes of GH deficiency in the paediatric age 191
A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. 190
A novel pathogenic MYH3 mutation in a child with Sheldon–Hall syndrome and vertebral fusions 190
Current perspective on the pathogenesis of central diabetes insipidus 189
X-linked agammaglobulinemia and isolated growth hormone deficiency. 188
Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations. 187
Management of diabetes insipidus and adipsia in the child. 184
Clinical Manifestations and Metabolic Outcomes of Seven Adults with Silver-Russell Syndrome 184
A case of multiple intestinal atresias, brain anomalies, mental retardation, growth hormone deficiency and clitoris hypertrophy. 181
Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: Study in patients with organic GHD 173
X-linked hypophosphatemic rickets: an Italian experts' opinion survey 172
Recombinant Human GH Replacement Therapy in Children with Pseudohypoparathyroidism Type Ia: First Study on the Effect on Growth. 170
Involvement of hormonal circadian secretion in the growth of HIV-infected children. 170
Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. 168
A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-€“Russell and Beckwith-€“Wiedemann syndromes 167
Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked 167
19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. 165
Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device 165
Contribution of LHX4 mutations to pituitary deficits in a cohort of 417 unrelated patients 164
Central adrenal insufficiency in children and adolescents 164
Pituitary gland imaging and outcome. 163
Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. 158
Prevalence and correlates of adherence in children and adolescents treated with growth hormone: A multicenter Italian study 158
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 158
Growth Hormone Deficiency in the Transition Age 158
Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone 158
Central diabetes insipidus in children and young adults. 155
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 155
Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. 155
Accuracy of Glucagon Testing Across Transition in Young Adults with Childhood-Onset Growth Hormone Deficiency 154
The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities. 153
Glucokinase mutations in pediatric patients with impaired fasting glucose 153
Plasma total adiponectin levels in pediatrics: Reference intervals calculated as a continuous variable of age. 153
Highly conserved non-coding sequences and the 18q critical region for short stature: a common mechanism of disease? 153
Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. 152
Cognitive and White Matter Microstructure Development in Congenital Hypothyroidism and Familial Thyroid Disorders 152
Relationships between neuroradiological and clinical features in apparently idiopathic hypopituitarism. 151
Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. 151
Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases 151
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 149
Growth Hormone Registry: A step forward in standard diagnostic practices in Italy. 148
Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations. 146
Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED) 145
Neuroimaging in Growth hormone deficiency 145
Adult height in children with short stature and idiopathic delayed puberty after different management. 145
Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. 144
Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. 143
Safety Outcomes during Pediatric GH Therapy: Final Results from the Prospective GeNeSIS Observational Program 143
Is growth hormone treatment in young children safe for the heart? 142
Midbrain-hindbrain involvement in septo-optic dysplasia. 142
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 142
Accuracy and limitations of the growth hormone (GH) releasing hormone-arginine retesting in young adults with childhood-onset GH deficiency 141
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. 139
The use of neuroimaging for assessing disorders of pituitary development. 138
Hypothalamic-pituitary dwarfism: comparison between MR imaging and CT findings. 138
Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development 138
Familial ROBO1 deletion associated with ectopic posterior pituitary, duplication of the pituitary stalk and anterior pituitary hypoplasia 138
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight Infants 138
Validation of the Italian Quality of Life in Short Stature Youth (QoLISSY) questionnaire 137
JAG1 loss-of-function variations as a novel predisposing event in the pathogenesis of congenital thyroid defects 137
Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. 137
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children. 136
Adult panhypopituritarism presenting as idiopathic growth hormone deficiency in childhood: really idiopathic? 136
Pituitary stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for? 136
Comparison of clinical-radiological and molecular findings in hypochondroplasia. 136
PREDICTIVE ROLE OF THE IMMUNOSTAINING PATTERN OF IMMUNOFLUORESCENCE AND THE TITERS OF ANTIPITUITARY ANTIBODIES AT PRESENTATION FOR THE OCCURRENCE OF AUTOIMMUNE HYPOPITUITARISM IN PATIENTS WITH AUTOIMMUNE POLYENDOCRINE SYNDROMES OVER A FIVE-YEAR FOLLOW-UP.. 136
Motor function improvement after intravenous pamidronate in osteoporosis pseudoglioma syndrome. 135
Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. 135
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 135
Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. 135
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections 135
T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study 135
Characterization of Two Novel Variants of the Steroidogenic Acute Regulatory Protein Identified in a Girl with Classic Lipoid Congenital Adrenal Hyperplasia 135
Disorders of salt and water balance in children. 134
Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. 133
The accuracy of magnetic resonance imaging and ultrasonography compared with surgical findings in the localization of the undescended testis. 133
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA. 133
Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. 133
Cognitive Profiles and Brain Volume Are Affected in Patients with Silver-Russell Syndrome 133
Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities. 132
GERMLINE PROKINETICIN RECEPTOR 2 (PROKR2) VARIANTS ASSOCIATED WITH CENTRAL HYPOGONADISM CAUSE DIFFERENTAL MODULATION OF DISTINCT INTRACELLULAR PATHWAYS. 132
The Accuracy of the Glucagon Test Compared to the Insulin Tolerance Test in the Diagnosis of Adrenal Insufficiency in Young Children with Growth Hormone Deficiency. 132
Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis. 131
Poland's syndrome associated with growth hormone deficiency. 131
Catch-up growth and height prognosis in early treated children with congenital hypopituitarism. 131
Evolution of childhood central diabetes insipidus into panhypopituitarism with a large hypothalamic mass: is 'lymphocytic infundibuloneurohypophysitis' in children a different entity? 131
TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism 131
Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study 131
Novel CNS malformations and skeletal anomalies in a patient with Beaulieu-boycott-Innes syndrome 131
Hypogonadism in a patient with balanced X/18 translocation and pituitary hormone deficiency. 130
Pituitary Tumors: Advances in Neuroimaging. 130
Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. 129
Hypopituitarism and stalk agenesis: a congenital syndrome worsened by breech delivery? 129
Totale 15.816
Categoria #
all - tutte 105.814
article - articoli 101.497
book - libri 0
conference - conferenze 298
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.019
Totale 211.628


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021492 0 0 0 0 0 0 0 0 0 224 95 173
2021/20222.632 86 165 183 201 134 147 169 696 114 267 84 386
2022/20232.746 289 167 53 271 401 519 6 236 486 23 260 35
2023/20242.007 75 227 483 198 123 245 131 99 67 58 79 222
2024/20254.947 122 398 125 377 588 520 469 687 217 300 542 602
2025/20267.583 1.052 225 642 667 1.094 804 1.327 440 727 605 0 0
Totale 33.154